Schrödinger (SDGR) Revenue & Revenue Breakdown
Schrödinger Revenue Highlights
Latest Revenue (Y)
$216.67M
Latest Revenue (Q)
$47.33M
Main Segment (Y)
Drug Discovery Contribution
Main Geography (Y)
UNITED STATES
Schrödinger Revenue by Period
Schrödinger Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 19.73% |
2022-12-31 | - | 31.19% |
2021-12-31 | - | 27.60% |
2020-12-31 | - | 26.36% |
2019-12-31 | - | 28.37% |
2018-12-31 | - | 19.65% |
2017-12-31 | - | - |
Schrödinger Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 29.33% |
2024-03-31 | - | -50.63% |
2023-12-31 | - | 74.13% |
2023-09-30 | - | 20.97% |
2023-06-30 | - | -45.68% |
2023-03-31 | - | 13.97% |
2022-12-31 | - | 53.71% |
2022-09-30 | - | -3.87% |
2022-06-30 | - | -20.95% |
2022-03-31 | - | 5.40% |
2021-12-31 | - | 54.67% |
2021-09-30 | - | 0.22% |
2021-06-30 | - | -7.29% |
2021-03-31 | - | -2.74% |
2020-12-31 | - | 28.05% |
2020-09-30 | - | 11.71% |
2020-06-30 | - | -11.78% |
2020-03-31 | - | 1.32% |
2019-12-31 | - | 29.42% |
2019-09-30 | - | 5.00% |
2019-06-30 | - | -8.35% |
2019-03-31 | - | 18.68% |
2018-12-31 | - | 34.51% |
2018-09-30 | - | -13.18% |
2018-06-30 | - | -17.25% |
2018-03-31 | - | - |
Schrödinger Revenue Breakdown
Schrödinger Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 22 | Dec 21 | Dec 20 |
---|---|---|---|
Drug Discovery Contribution | - | - | - |
Software Contribution | - | - | - |
Hosted Software | - | - | - |
Software Products And Services | - | - | - |
Revenue From Contract With Customer Before Software Contribution | - | - | - |
Professional Services | - | - | - |
On Premise Software | - | - | - |
Maintenance | - | - | - |
Revenue From Contract With Customer Before Contribution | - | - | - |
Contribution | - | - | - |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hosted Software | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue From Contract With Customer Before Contribution | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Maintenance | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
On Premise Software | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Professional Services | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Software Products And Services | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Contribution | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Drug Discovery Contribution | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Drug Discovery Services | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Drug Discovery Services Revenue From Contracts With Customers | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Drug Discovery | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Latest
Schrödinger Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 22 | Dec 21 | Dec 20 |
---|---|---|---|
JAPAN | - | - | - |
Non-US | - | - | - |
UNITED STATES | - | - | - |
Europe | - | - | - |
Non Us | - | - | - |
Latest
Quarterly Revenue by Country
Country | Sep 24 | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Non-US | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EMEA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
APAC | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
UNITED STATES | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
JAPAN | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Europe | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Non Us | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
U S | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
J P | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Latest